THE ROLE OF ASYMMETRIC DIMETHYLARGININE AS A PREDICTOR OF CARDIOVASCULAR DISEASES

Please use this identifier to cite or link to this item: http://repo.tma.uz/xmlui/handle/1/204

Full metadata record

DC Field	Value	Language
dc.contributor.author	Makhkamova M.M., Nurillaeva N.M	-
dc.date.accessioned	2024-11-22T10:47:19Z	-
dc.date.available	2024-11-22T10:47:19Z	-
dc.date.issued	2024	-
dc.identifier.issn	2181-7812	-
dc.identifier.uri	http://repo.tma.uz/xmlui/handle/1/204	-
dc.description.abstract	Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase (NOS), an enzyme responsible for producing nitric oxide (NO), a molecule with various cardiovascular protective effects including vasodilation and inhibition of platelet aggregation. Elevated levels of ADMA have been associated with endothelial dysfunction, inflammation, and oxidative stress, all of which are key factors in the development and progression of cardiovascular diseases (CVD).	en_US
dc.language.iso	en	en_US
dc.publisher	Вестник ТМА	en_US
dc.subject	Asymmetric dimethylarginine, cardiovascular disease, nitric oxide synthase, endothelial dysfunction, l-arginine.	en_US
dc.title	THE ROLE OF ASYMMETRIC DIMETHYLARGININE AS A PREDICTOR OF CARDIOVASCULAR DISEASES	en_US
dc.type	Article	en_US
Appears in Collections:	Articles

Files in This Item:

File	Description	Size	Format
20 Махкамова ,Нуриллаева Н.М..pdf	THE ROLE OF ASYMMETRIC DIMETHYLARGININE AS A PREDICTOR OF CARDIOVASCULAR DISEASES	991.09 kB	Adobe PDF	View/Open

DSpace JSPUI